Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B

作者: Yu Sun , Judith Campisi , Celestia Higano , Tomasz M Beer , Peggy Porter

DOI: 10.1038/NM.2890

关键词:

摘要: Acquired resistance to anticancer treatments is a substantial barrier reducing the morbidity and mortality that attributable malignant tumors. Components of tissue microenvironments are recognized profoundly influence cellular phenotypes, including susceptibilities toxic insults. Using genome-wide analysis transcriptional responses genotoxic stress induced by cancer therapeutics, we identified spectrum secreted proteins derived from tumor microenvironment includes Wnt family member wingless-type MMTV integration site 16B (WNT16B). We determined WNT16B expression regulated nuclear factor κ light polypeptide gene enhancer in B cells 1 (NF-κB) after DNA damage subsequently signals paracrine manner activate canonical program cells. The prostate attenuated effects cytotoxic chemotherapy vivo, promoting cell survival disease progression. These results delineate mechanism which therapies given cyclical can enhance subsequent treatment through nonautonomous contributed microenvironment.

参考文章(46)
Jong In Yook, Xiao-Yan Li, Ichiro Ota, Casey Hu, Hyun Sil Kim, Nam Hee Kim, So Young Cha, Joo Kyung Ryu, Yoon Jung Choi, Jin Kim, Eric R. Fearon, Stephen J. Weiss, A Wnt–Axin2–GSK3β cascade regulates Snail1 activity in breast cancer cells Nature Cell Biology. ,vol. 8, pp. 1398- 1406 ,(2006) , 10.1038/NCB1508
Narendra Wajapeyee, Ryan W. Serra, Xiaochun Zhu, Meera Mahalingam, Michael R. Green, Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7 Cell. ,vol. 132, pp. 363- 374 ,(2008) , 10.1016/J.CELL.2007.12.032
David G. DeNardo, Donal J. Brennan, Elton Rexhepaj, Brian Ruffell, Stephen L. Shiao, Stephen F. Madden, William M. Gallagher, Nikhil Wadhwani, Scott D. Keil, Sharfaa A. Junaid, Hope S. Rugo, E. Shelley Hwang, Karin Jirström, Brian L. West, Lisa M. Coussens, Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy Cancer Discovery. ,vol. 1, pp. 54- 67 ,(2011) , 10.1158/2159-8274.CD-10-0028
O. Tredan, C. M. Galmarini, K. Patel, I. F. Tannock, Drug Resistance and the Solid Tumor Microenvironment Journal of the National Cancer Institute. ,vol. 99, pp. 1441- 1454 ,(2007) , 10.1093/JNCI/DJM135
F. Wang, R. K. Hansen, D. Radisky, T. Yoneda, M. H. Barcellos-Hoff, O. W. Petersen, E. A. Turley, M. J. Bissell, Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. Journal of the National Cancer Institute. ,vol. 94, pp. 1494- 1503 ,(2002) , 10.1093/JNCI/94.19.1494
David Bernard, Karo Gosselin, Didier Monte, Chantal Vercamer, Fatima Bouali, Albin Pourtier, Bernard Vandenbunder, Corinne Abbadie, Involvement of Rel/Nuclear Factor-κB Transcription Factors in Keratinocyte Senescence Cancer Research. ,vol. 64, pp. 472- 481 ,(2004) , 10.1158/0008-5472.CAN-03-0005
R.S. Kerbel, Molecular and Physiologic Mechanisms of Drug Resistance in Cancer: An Overview Cancer and Metastasis Reviews. ,vol. 20, pp. 1- 2 ,(2001) , 10.1023/A:1013129128673
Clemens A. Schmitt, Christine T. Rosenthal, Scott W. Lowe, Genetic analysis of chemoresistance in primary murine lymphomas Nature Medicine. ,vol. 6, pp. 1029- 1035 ,(2000) , 10.1038/79542
Janet Gross, Michael D. Green, Patricia M. Alderton, Comparative study of doxorubicin, mitoxantrone, and epirubicin in combination with ICRF-187 (ADR-529) in a chronic cardiotoxicity animal model. Cancer Research. ,vol. 52, pp. 194- 201 ,(1992)
Jean Paul Thiery, Hervé Acloque, Ruby Y.J. Huang, M. Angela Nieto, Epithelial-Mesenchymal Transitions in Development and Disease Cell. ,vol. 139, pp. 871- 890 ,(2009) , 10.1016/J.CELL.2009.11.007